Cargando…

Antibody response to a third dose of SARS‐CoV‐2 vaccine in heart and lung transplant recipients

Detalles Bibliográficos
Autores principales:	Alejo, Jennifer L., Ruck, Jessica M., Chiang, Teresa P. Y., Abedon, Aura T., Kim, Jake D., Avery, Robin K., Tobian, Aaron A. R., Warren, Daniel S., Levan, Macey L., Massie, Allan B., Garonzik‐Wang, Jacqueline M., Segev, Dorry L., Werbel, William A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538949/ https://www.ncbi.nlm.nih.gov/pubmed/36073912 http://dx.doi.org/10.1111/ctr.14818

Ejemplares similares

Heterologous Ad.26.COV2.S versus homologous BNT162b2/mRNA-1273 as a third dose in solid organ transplant recipients seronegative after two-dose mRNA vaccination
por: Chiang, Teresa PY, et al.
Publicado: (2022)

Severe acute respiratory syndrome coronavirus 2 antibody response to a third dose of homologous messenger RNA vaccination in liver transplantation recipients
por: Strauss, Alexandra T., et al.
Publicado: (2022)

Incident COVID-19 and Hospitalizations by Variant Era Among Vaccinated Solid Organ Transplant Recipients
por: Chiang, Teresa Po-Yu, et al.
Publicado: (2023)

Letter to the editor: Six‐month antibody kinetics and durability in liver transplant recipients after two doses of SARS‐CoV‐2 mRNA vaccination
por: Chang, Amy, et al.
Publicado: (2022)

Antibody Kinetics and Durability in SARS-CoV-2 mRNA Vaccinated Solid Organ Transplant Recipients
por: Boyarsky, Brian J., et al.
Publicado: (2021)

Transplantation Amid a Pandemic: The Fall and Rise of Kidney Transplantation in the United States
por: Bisen, Shivani S., et al.
Publicado: (2022)

Neutralizing activity and 3-month durability of tixagevimab and cilgavimab prophylaxis against Omicron sublineages in transplant recipients
por: Karaba, Andrew H., et al.
Publicado: (2023)

Quantifying excess deaths among solid organ transplant recipients in the COVID‐19 era
por: Massie, Allan B., et al.
Publicado: (2022)

A Third Dose of SARS-CoV-2 Vaccine Increases Neutralizing Antibodies Against Variants of Concern in Solid Organ Transplant Recipients
por: Karaba, Andrew H., et al.
Publicado: (2021)

A third dose of SARS-CoV-2 vaccine increases neutralizing antibodies against variants of concern in solid organ transplant recipients
por: Karaba, Andrew H., et al.
Publicado: (2022)

SARS-CoV-2 messenger RNA vaccine antibody response and reactogenicity in heart and lung transplant recipients
por: Hallett, Andrew M., et al.
Publicado: (2021)

Heterologous versus homologous boosting elicits qualitatively distinct, BA.5–cross-reactive T cells in transplant recipients
por: Thompson, Elizabeth A., et al.
Publicado: (2023)

Kidney Transplant Recipient Attitudes Toward a SARS-CoV-2 Vaccine
por: Ou, Michael T., et al.
Publicado: (2021)

Effects of COVID19 Pandemic on Pediatric Kidney Transplant in the United States
por: Charnaya, Olga, et al.
Publicado: (2020)

A Fourth Dose of COVID-19 Vaccine Does Not Induce Neutralization of the Omicron Variant Among Solid Organ Transplant Recipients With Suboptimal Vaccine Response
por: Karaba, Andrew H., et al.
Publicado: (2022)

Comparison of SARS-CoV-2 Antibody Response After 2-Dose mRNA-1273 vs BNT162b2 Vaccines in Incrementally Immunosuppressed Patients
por: Mitchell, Jonathan, et al.
Publicado: (2022)

SARS-CoV-2 antibody testing for transplant recipients: A tool to personalize protection versus COVID-19
por: Werbel, William A., et al.
Publicado: (2022)

Interviews of living kidney donors to assess donation-related concerns and information-gathering practices
por: Ruck, Jessica M., et al.
Publicado: (2018)

Trends and three-year outcomes of hepatitis C virus–viremic donor heart transplant for hepatitis C virus–seronegative recipients
por: Ruck, Jessica M., et al.
Publicado: (2022)

Factors associated with poor antibody response to third-dose SARS-CoV-2 vaccination in patients with rheumatic and musculoskeletal diseases
por: Connolly, Caoilfhionn M, et al.
Publicado: (2022)

Effects of COVID-19 pandemic on pediatric kidney transplant in the United States
por: Charnaya, Olga, et al.
Publicado: (2020)

Liver transplantation in the United States during the COVID-19 pandemic: National and center-level responses
por: Strauss, Alexandra T., et al.
Publicado: (2021)

Safety and antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in patients with multiple myeloma
por: Greenberg, Ross S., et al.
Publicado: (2021)

Inpatient COVID-19 outcomes in solid organ transplant recipients compared to non-solid organ transplant patients: A retrospective cohort
por: Avery, Robin K., et al.
Publicado: (2021)

Outcomes of SOT Recipients With COVID-19 in Different Eras of COVID-19 Therapeutics
por: Sait, Afrah S., et al.
Publicado: (2021)

Persistent SARS-CoV-2–specific immune defects in kidney transplant recipients following third mRNA vaccine dose
por: Werbel, William A., et al.
Publicado: (2023)

Financial incentives versus standard of care to improve patient compliance with live kidney donor follow-up: protocol for a multi-center, parallel-group randomized controlled trial
por: Levan, Macey L., et al.
Publicado: (2020)

175 The Unfinished Journey towards Transplant Equity: an analysis of racial/ethnic disparities for children in the post-KAS era
por: Charnaya, Olga, et al.
Publicado: (2022)

Short Report: Evaluating the Effects of Automated Donor Referral Technology on Deceased Donor Referrals
por: Levan, Macey L., et al.
Publicado: (2022)

Kidney Dyads: Caregiver Burden and Relationship Strain Among Partners of Dialysis and Transplant Patients
por: Van Pilsum Rasmussen, Sarah E., et al.
Publicado: (2020)

Assessing the Attitudes and Perceptions Regarding the Use of Mobile Health Technologies for Living Kidney Donor Follow-Up: Survey Study
por: Eno, Ann K, et al.
Publicado: (2018)

Safety of third-dose SARS-CoV-2 vaccination in patients with rheumatic and musculoskeletal disease
por: Connolly, Caoilfhionn M, et al.
Publicado: (2022)

Cancer Risk Following HLA-Incompatible Living Donor Kidney Transplantation
por: Motter, Jennifer D., et al.
Publicado: (2023)

The Impact of the mKidney mHealth System on Live Donor Follow-Up Compliance: Protocol for a Randomized Controlled Trial
por: Henderson, Macey L, et al.
Publicado: (2019)

Antibody durability 6 months after two doses of SARS-CoV-2 mRNA vaccines in patients with rheumatic and musculoskeletal disease
por: Frey, Sarah, et al.
Publicado: (2022)

Trends in Heart and Lung Transplantation in the United States Across the COVID-19 Pandemic
por: Hallett, Andrew, et al.
Publicado: (2021)

Early Experiences With COVID-19 Testing in Transplantation
por: Boyarsky, Brian J., et al.
Publicado: (2020)

Kidney Transplantation Confers Survival Benefit for Candidates With Pulmonary Hypertension
por: Nguyen, Michelle C., et al.
Publicado: (2021)

Addressing Racial Disparities in Live Donor Kidney Transplantation Through Education and Advocacy Training
por: King, Elizabeth A., et al.
Publicado: (2020)

Quantifying infection risks in incompatible living donor kidney transplant recipients
por: Avery, Robin K., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jv0d7v5ks0j0b9a7jcfp7f94ji